Clinical Trial Update: Methylphenidate and Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methylphenidate for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED